Evidence map›Paper›PMID 40959675›Full record

ArticleCureus2025

Chyluria Status Post Microwave Ablation of Renal Cell Carcinoma: A Case Report.

Shervin Arjomand, Andrew R Sawan, James Park, Chul Chae

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shervin ArjomandRadiology, California University of Science and Medicine, Colton, USA.
Andrew R SawanRadiology, Arrowhead Regional Medical Center, Colton, USA.
James ParkMedical Imaging, Arrowhead Regional Medical Center, Colton, USA.
Chul ChaeMedical Imaging, Arrowhead Regional Medical Center, Colton, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microwave ablation is a minimally invasive alternative to nephrectomy for select patients with renal cell carcinoma (RCC), particularly those with solitary kidneys or significant comorbidities. We present a case of a 55-year-old male with stage 3B chronic kidney disease and biopsy-confirmed clear cell RCC who underwent successful microwave ablation. Post-procedure imaging demonstrated a stable lesion size without recurrence. However, follow-up revealed persistent chyluria, likely as a rare and delayed consequence of ablation. This report discusses the pathophysiology, diagnostic considerations, and clinical implications of chyluria in the post-ablation setting.

Indexed as

abdominal radiologychyluriafat-fluid levelradiofrequency ablation (rfa)renal cell carcinoma (rcc)

Identifiers

PMID40959675
PMCPMC12435593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.